P.A.W. Capital’s Fortress Biotech FBIO Stock Holding History

P.A.W. Capital’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-6,000	Closed	-$347K	–	69
2015 Q1	$347K	Buy	+6,000	New	+$250K	0.34%	67

Other funds holding FBIO

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BGA

Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

P.A.W. Capital's FBIO Position: Q2 2015 in Review

P.A.W. Capital sold out of Fortress Biotech (FBIO) in Q2 2015, closing a stake of 6,000 shares — an estimated $347K sold.

P.A.W. Capital first reported a position in FBIO in Q1 2015 and held it in 1 quarter. The position peaked at $347K in Q1 2015. 41 funds tracked by Wall St. Rank hold FBIO as of Q2 2015.

P.A.W. Capital reported no remaining Fortress Biotech position as of Q2 2015 after selling out during the quarter.
P.A.W. Capital sold 6,000 Fortress Biotech shares in Q2 2015, an estimated $347K.
P.A.W. Capital first reported a position in Fortress Biotech in Q1 2015 and held it in 1 quarter.
P.A.W. Capital's Fortress Biotech position peaked at $347K in Q1 2015.
41 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2015.

Based on P.A.W. Capital's 13F filing for Q2 2015, filed 31 Jul 2015.